Two Cases of Mastectomy after Paclitaxel + Bevacizumab Therapy for Locally Advanced Breast Cancer

Publisher： Karger

E-ISSN： 1662-6575|7|2|323-329

ISSN： 1662-6575

Source： Case Reports in Oncology, Vol.7, Iss.2, 2014-05, pp. : 323-329

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Weekly Paclitaxel Combined with Local Hyperthermia in the Therapy of Breast Cancer Locally Recurrent after Mastectomy – a Pilot Experience

By  

Oncology Research and Treatment, Vol. 27, Iss. 4, 2004-09 ,pp. : 385-388

Karger

Access to resources Recommend Favorite

Paclitaxel plus bevacizumab increases disease-free survival in women with advanced breast cancer

By  

Women's Health, Vol. 2, Iss. 3, 2006-05 ,pp. : 327-329

Future Medicine

Access to resources Recommend Favorite

Long-Term Complete Remission with nab-Paclitaxel, Bevacizumab, and Gemcitabine Combination Therapy in a Patient with Triple-Negative Metastatic Breast Cancer

By  

Case Reports in Oncology, Vol. 5, Iss. 3, 2012-12 ,pp. : 687-692

Karger

Access to resources Recommend Favorite

Prospective Phase II Study of Neoadjuvant Therapy with Cisplatin, 5-Fluorouracil, and Bevacizumab for Locally Advanced Resectable Esophageal Cancer

By  

Oncology Research and Treatment, Vol. 35, Iss. 7-8, 2012-07 ,pp. : 427-431

Karger

Access to resources Recommend Favorite

Breast cancer in BRCA mutation carriers: breast-conserving therapy or bilateral mastectomy?

By Murphy James O   Sacchini Virgilio S  

Clinical Practice, Vol. 10, Iss. 6, 2013-11 ,pp. : 751-764

Future Medicine

Access to resources Recommend Favorite